drugset / Trial / NCT06520059
Optimal Articular Solutions With Intraosseous and Synovial Platelet-Rich Plasma
Non-randomizedParallel-groupSingle-blindTreatment
Summary
This is a prospective cohort clinical study. Due to logistic constraints at the sites of implementation, a randomized allocation will not be feasible (private clinic). Patients will be selected with the aim of matching for important confounders (sex and age) the grade of knee OA will be restricted to advance stages.
Timeline
- Start
- 2025-01-01
- Primary completion
- 2026-07-31
- Completion
- 2027-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | 4 ml | Other |
| Subject | Platelet Rich Plasma | Other / unclassified | 6 ml | Other |
| Subject | Platelet Rich Plasma | Other / unclassified | 8 ml | Other |